PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Detail   |   Print    Next page > 
     
Henlius Reports 2026 Interim Results: Sustained Profitability Leap, Advancing Global Value Validation
2026-08-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Coreline Soft and INFINITT North America Deploy Chest CT-Based AI Reading Workflow at St. Joseph's Health
2026-08-21T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
CureGene Completes First‑Participant Dose in Phase I Trial of CG‑0416, Advancing Clinical Development of Novel Oral Liver-Targeting THR-β Agonist
2026-08-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
China's Personalized mRNA Cancer Therapy Sector Accelerates: How Far Is It From a "DeepSeek Moment"?
2026-08-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) NDA Accepted by NMPA, Poised to Become World's First Approved 4-1BB-Targeting Therapy
2026-08-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Dizal to Present Emerging Data on ZEGFROVY® in Non-Small Cell Lung Cancer at WCLC 2026
2026-08-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth
2026-08-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
/C O R R E C T I O N -- Akeso, Inc./
2026-08-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Sunshine Guojian Releases 2026 Interim Report:
2026-08-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results
2026-08-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.